Author:
García-Aparicio Carlos,Diez-Torrubia Alberto,Balzarini Jan,Lambeir Anne-Marie,Velázquez Sonsoles,Camarasa María-José
Reference17 articles.
1. The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors;Augustyns;Curr. Med. Chem.,1999
2. 2′,5′-Bis-O-(tert-butyldimethylsilyl)-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)pyrimidine (TSAO) nucleoside analogues: highly selective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase;Balzarini;Proc. Natl. Acad. Sci. U.S.A.,1992
3. Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]3-N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide);Balzarini;Biochem. Pharmacol.,1993
4. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH2);Balzarini;Int. J. Biochem. Cell Biol.,2004
5. Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position;Bonache;J. Med. Chem.,2005
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献